Changes to 340B Program Finalized
The Biden administration recently issued a rule making changes to the 340B drug discount program’s dispute resolution process. The…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
OPDP Considers Potential Misleading Implications of Television Ads
Recently, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) research team…
DOJ Files Complaint in Intervention Against Regeneron Pharmaceuticals in…
The United States Department of Justice (DOJ) recently intervened in a False Claims Act case against Regeneron Pharmaceuticals…
Connecticut Pharmaceutical Reporting Deadline Approaches: New FAQ Document…
With less than two weeks before the Connecticut reporting deadline for pharmaceutical companies to report representative…
Prominently Displaying Methodology of Studies Improves Physician Perception…
A recent research piece published in the Research in Social and Administrative Pharmacy by the Food and Drug Administration (FDA)…
HHS Releases White Paper on Drug Shortages, Solutions
Recently, the United States Department of Health and Human Services (HHS) issued a white paper, “Policy Considerations to Prevent…
Nurse Practitioner to Serve Prison Time for Role in Telemedicine Health…
Recently, Daphne Jenkins, a Virginia-based nurse practitioner, was sentenced to 18 months in prison followed by two years of…
Summary of Section 1557 of the Affordable Care Act and Application for…
The United States Department of Health and Human Services (HHS) has issued a final rule under Section 1557 of the Affordable Care…
DOJ Joins Anti-Kickback Lawsuit Against Florida Pharmacies
Recently, the Department of Justice (DOJ) joined a whistleblower lawsuit against several Florida pharmacies and pharmacy owners,…
FTC Finalizes Changes to the Health Breach Notification Rule
The United States Federal Trade Commission (FTC) recently finalized a rule, strengthening and modernizing the Health Breach…